Nuvalent Stock Total Asset

NUVL Stock  USD 84.22  0.42  0.50%   
Nuvalent fundamentals help investors to digest information that contributes to Nuvalent's financial success or failures. It also enables traders to predict the movement of Nuvalent Stock. The fundamental analysis module provides a way to measure Nuvalent's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nuvalent stock.
Last ReportedProjected for Next Year
Total Assets732.4 M769 M
Total Assets is expected to rise to about 769 M this year.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Nuvalent Company Total Asset Analysis

Nuvalent's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.

Total Asset

 = 

Tangible Assets

+

Intangible Assets

More About Total Asset | All Equity Analysis

Current Nuvalent Total Asset

    
  732.38 M  
Most of Nuvalent's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nuvalent is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Nuvalent Total Asset Driver Correlations

Understanding the fundamental principles of building solid financial models for Nuvalent is extremely important. It helps to project a fair market value of Nuvalent Stock properly, considering its historical fundamentals such as Total Asset. Since Nuvalent's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Nuvalent's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Nuvalent's interrelated accounts and indicators.
1.00.990.68-0.99-0.990.910.90.191.01.01.0-0.80.910.910.9
1.00.990.67-0.99-0.990.910.890.171.01.01.0-0.80.910.90.89
0.990.990.72-0.97-0.960.930.840.10.990.990.99-0.820.950.890.89
0.680.670.72-0.65-0.640.710.570.310.670.680.68-0.970.80.570.58
-0.99-0.99-0.97-0.650.99-0.94-0.9-0.26-0.99-0.99-0.990.78-0.89-0.95-0.95
-0.99-0.99-0.96-0.640.99-0.91-0.94-0.3-0.99-0.99-0.990.78-0.87-0.93-0.92
0.910.910.930.71-0.94-0.910.850.230.910.910.91-0.810.950.970.98
0.90.890.840.57-0.9-0.940.850.450.890.90.9-0.740.780.880.85
0.190.170.10.31-0.26-0.30.230.450.170.190.19-0.370.020.320.3
1.01.00.990.67-0.99-0.990.910.890.171.01.0-0.80.910.90.89
1.01.00.990.68-0.99-0.990.910.90.191.01.0-0.80.910.910.9
1.01.00.990.68-0.99-0.990.910.90.191.01.0-0.810.910.910.9
-0.8-0.8-0.82-0.970.780.78-0.81-0.74-0.37-0.8-0.8-0.81-0.87-0.71-0.71
0.910.910.950.8-0.89-0.870.950.780.020.910.910.91-0.870.860.87
0.910.90.890.57-0.95-0.930.970.880.320.90.910.91-0.710.861.0
0.90.890.890.58-0.95-0.920.980.850.30.890.90.9-0.710.871.0
Click cells to compare fundamentals

Nuvalent Total Asset Historical Pattern

Today, most investors in Nuvalent Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Nuvalent's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total asset growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Nuvalent total asset as a starting point in their analysis.
   Nuvalent Total Asset   
       Timeline  
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
Competition

Nuvalent Total Assets

Total Assets

769 Million

At this time, Nuvalent's Total Assets are quite stable compared to the past year.
Based on the latest financial disclosure, Nuvalent has a Total Asset of 732.38 M. This is 90.26% lower than that of the Biotechnology sector and 62.93% lower than that of the Health Care industry. The total asset for all United States stocks is 97.51% higher than that of the company.

Nuvalent Total Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nuvalent's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nuvalent could also be used in its relative valuation, which is a method of valuing Nuvalent by comparing valuation metrics of similar companies.
Nuvalent is currently under evaluation in total asset category among its peers.

Nuvalent ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Nuvalent's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Nuvalent's managers, analysts, and investors.
Environmental
Governance
Social

Nuvalent Institutional Holders

Institutional Holdings refers to the ownership stake in Nuvalent that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Nuvalent's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Nuvalent's value.
Shares
T. Rowe Price Associates, Inc.2024-09-30
1.1 M
Wellington Management Company Llp2024-09-30
M
Commodore Capital Lp2024-09-30
940 K
Driehaus Capital Management Llc2024-09-30
864 K
Geode Capital Management, Llc2024-09-30
855.6 K
Fred Alger Management, Llc2024-09-30
627.7 K
Pictet Asset Manangement Sa2024-09-30
621.1 K
Morgan Stanley - Brokerage Accounts2024-09-30
471.7 K
Rock Springs Capital Management Lp2024-09-30
430 K
Deerfield Management Co2024-09-30
20 M
Fmr Inc2024-09-30
9.7 M

Nuvalent Fundamentals

About Nuvalent Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Nuvalent's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nuvalent using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nuvalent based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Nuvalent is a strong investment it is important to analyze Nuvalent's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nuvalent's future performance. For an informed investment choice regarding Nuvalent Stock, refer to the following important reports:
Check out Nuvalent Piotroski F Score and Nuvalent Altman Z Score analysis.
For more information on how to buy Nuvalent Stock please use our How to buy in Nuvalent Stock guide.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nuvalent. If investors know Nuvalent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nuvalent listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.49)
Return On Assets
(0.19)
Return On Equity
(0.30)
The market value of Nuvalent is measured differently than its book value, which is the value of Nuvalent that is recorded on the company's balance sheet. Investors also form their own opinion of Nuvalent's value that differs from its market value or its book value, called intrinsic value, which is Nuvalent's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nuvalent's market value can be influenced by many factors that don't directly affect Nuvalent's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nuvalent's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nuvalent is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nuvalent's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.